NeueHealth, Inc. (NYSE:NEUE - Get Free Report)'s stock price fell 0.5% during mid-day trading on Thursday . The company traded as low as $6.47 and last traded at $6.52. 12,641 shares traded hands during trading, an increase of 91% from the average session volume of 6,626 shares. The stock had previously closed at $6.55.
NeueHealth Trading Down 0.5%
The firm has a market cap of $58.84 million, a price-to-earnings ratio of -0.41 and a beta of 0.57. The stock has a 50-day moving average of $6.79 and a 200-day moving average of $6.76.
NeueHealth (NYSE:NEUE - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported ($1.68) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.77) by $3.09. The company had revenue of $209.08 million for the quarter, compared to analyst estimates of $249.50 million. As a group, research analysts expect that NeueHealth, Inc. will post -9.13 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the business. Northern Trust Corp boosted its position in NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company's stock worth $242,000 after acquiring an additional 13,074 shares during the period. PenderFund Capital Management Ltd. acquired a new position in NeueHealth during the 1st quarter worth $197,000. Finally, Skandinaviska Enskilda Banken AB publ acquired a new position in NeueHealth during the 2nd quarter worth $201,000. Institutional investors and hedge funds own 63.88% of the company's stock.
NeueHealth Company Profile
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NeueHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.
While NeueHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.